Dr. Behrooz Z. Alizadeh is an MD, and specialist in genetic epidemiology who obtained his MD from TUMS Tehran (1997), graduated in MSc (2001) and DSc (2002) degree from NIHES, Rotterdam, his Ph.D. from EMC-EU, Rotterdam (2005), and completed his postdoctoral fellowship in functional ImmunoGenomics at UMC Utrecht (2007). Since 2009, he is a staff member of the department of Epidemiology acting as the head of the unit of Personalized medicine (2016) and is a member of the board of several research and/or educational programs and committees at UMCG Groningen, at METC UMCG (2012), and scientific international institutions. He holds visiting professor positions at several universities and is leading several (inter)national research projects (eg. Mindlines, GROUP, RadioGenomics, ARAS, CHARGE). During the 17 years of his scientific career, he published >200 publications of which the majority are in the top 10% of high-impact peer-reviewed journals. He is the principal investigator of educational institutes (eg. GUIDE, SHARE, GSMS, CPE) in the Netherlands. He has (co)supervised 20 PhDs fellows and postdocs. His current research is focused on the devising, modeling, but also clinical, and societal implementation of personalized medicine in cancer and psychosis. To this end, his research group utilizes and integrates heterogeneous data from various domains of genomics, exposome, clinical, medications, and patient-reported outcomes. In his view, personalized medicine is a health care process or even a societal program, rather than a research outcome!
|Last modified:||19 August 2022 5.39 p.m.|